ATX-101 Abdominoplasty (ATX-101-08-10)

Kythera Biopharmaceuticals

Status and phase: Completed; Phase 1

Conditions: Characteristics of Subcutaneous Fat

Treatments: Drug: ATX-101

Study type: Interventional

Funder types: Industry

Identifiers

NCT00835952

ATX-101-08-10

Details and patient eligibility

About

Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty

Enrollment: 14 estimated patients

Sex: All

Ages: 25 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy subjects undergoing planned abdominoplasty

Exclusion criteria

• History of interventions in the abdominal area

Trial design

Primary purpose: Basic Science

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

14 participants in 1 patient group

ATX-101

Experimental group

Treatment:

Drug: ATX-101